Skip to content

Take it Personal!+: a personalized treatment for substance use disorder in people with mild intellectual disability and borderline intellectual functioning

Evaluating a personalized treatment for substance use disorder in people with mild intellectual disability and borderline intellectual functioning: a series single case studies with a randomized multiple baseline design

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26987
Enrollment
15
Registered
2019-07-02
Start date
2019-03-27
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance use disorder, intellectual disabilities

Interventions

Take it Personal!+ is a personalized treatment based on motivational interviewing and cognitive behavioural therapy. Take it Personal!+ last 11 weeks with two sessions (Session A and B) a week, of 45

Sponsors

ZonMw Mr. F. Couvee stichting
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) A MID-BIF (IQ between 60-85), 2) diagnosed with a mild or moderate substance use disorder according to the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; APA, 2013) in cannabis, alcohol, XTC, cocaine or speed, 3) use the substance on at least three days of the week, 4) proficient in Dutch language, and 5) has a network (professional and/or social) that is able to support the treatment goals of the client.

Exclusion criteria

Exclusion criteria: 1) Risk of withdrawal symptoms, 2) severe psychiatric comorbidity, such as suicidality, psychosis or major depressive disorder, 3) severe somatic problems, and 4) psychosocial problems that interfere with treatment.

Design outcomes

Primary

MeasureTime frame
Substance use assessed with a daily diary method during the baseline phase, intervention phase and post treatment.

Secondary

MeasureTime frame
Personal and social recovery assessed with the standardized questionnaire ‘Ben ik tevreden?’ (BIT) (Van Biene, 2014) during baseline phase, post-treatment and follow-up phase. Craving, positive and negative affect assessed with the daily diary method during the baseline phase, intervention phase and post-treatment (e.g. How happy were you today? Did you have a desire to use the substance today?) Substance use measured with the Substance Use and Misuse in Intellectual Disability - Questionnaire (SUMID-Q) (Van Der Nagel, Kiewik, Van Dijk, De Jong, & Didden, 2011)

Contacts

Public ContactLotte Gosens

Pluryn / Radboud University

lgosens@pluryn.nl0652698429

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)